Organisation paid for research Program year 2024 Source: CMS Open Payments

Gcga Physicians Inc Dba

Neither a doctor nor a teaching hospital

Research payments

$39,812

16 payments

Through program year 2024, Gcga Physicians Inc Dba is reported as receiving $39,812 in research payments, across 16 payments.

By program year

4 rows
Year Kind Amount Payments
2024 Research $981 1
2023 Research $11,362 3
2022 Research $16,125 7
2021 Research $11,345 5

Breakdown

Who paid Research payments · program years 2021–2024
  1. Takeda Pharmaceuticals U.S.A., Inc. $39,812 16 payments
Studies the money was for Research payments · program years 2021–2024
  1. A Phase 3 Long-Term Safety Extension Study of Shp647 in Subjects With Moderate to Severe Ulcerative Colitis (Aida) $38,436 14 payments
  2. A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Study of Shp647 As Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (Figaro UC 301) $1,376 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record